Systematic Review of Methemoglobinemia in Acetaminophen Poisoning

Kamal Kant Sahu1, Susan V George1, Ahmad Daniyal Siddiqui2

  • 1Department of Medicine, Saint Vincent Hospital, Worcester, Massachusetts, United States.

Abstract

Insights

Acetaminophen (APAP) poisoning can rarely cause methemoglobinemia. Early recognition of this uncommon complication is crucial for prompt medical intervention and improved patient outcomes.

Area of Science:

  • Toxicology
  • Emergency Medicine
  • Clinical Pathology

Background:

  • Acetaminophen (APAP) toxicity is a frequent emergency department presentation.
  • Methemoglobinemia is an infrequent but serious complication of APAP overdose.

Purpose of the Study:

  • To review and analyze published cases of acetaminophen-induced methemoglobinemia.
  • To highlight the clinical features, management, and outcomes of this rare condition.

Main Methods:

  • A retrospective analysis of published case reports from 1968 to 2019.
  • Inclusion criteria focused on cases of methemoglobinemia associated with APAP ingestion.

Main Results:

  • 14 cases were identified (9 female, 6 male), with a median age of 59.
  • Altered mentation and cyanosis were common presentations; median methemoglobin level was 15.85%.
  • Treatments included NAC, hemodialysis, methylene blue; 9 patients recovered, 4 died.

Conclusions:

  • Acetaminophen toxicity can present with diverse and severe complications.
  • Methemoglobinemia is a critical, non-classical presentation of APAP toxicity requiring heightened clinical awareness.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.4K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
117
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
693
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.1K
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
608
Antidotes01:17

Antidotes

Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
949